| 2025-11-19 |
详情>>
内部人交易：
Sinha Saurabh股份减少48086.00股
|
| 2025-11-07 |
详情>>
股本变动：
变动后总股本6007.99万股
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.15美元,归母净利润-1.2亿美元,同比去年增长-3.44%
|
| 2025-11-05 |
财报披露：
美东时间 2025-11-05 盘后发布财报
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益-4.14美元,归母净利润-2.28亿美元,同比去年增长-189.14%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.64美元,归母净利润-3486.7万美元,同比去年增长1.30%
|
| 2025-04-30 |
股东大会：
将于2025-06-20召开股东大会
会议内容 ▼▲
- 1.Elect the two Class I directors named as nominees in this Proxy Statement to hold office until the 2028 annual meeting of stockholders (the “2028 Annual Meeting”) and until their respective successors have been duly elected and qualified;
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.Approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.Transact any other business properly introduced at the Annual Meeting.
|
| 2025-03-21 |
详情>>
业绩披露：
2022年年报每股收益-3.39美元,归母净利润-1.47亿美元,同比去年增长-44.59%
|
| 2025-03-21 |
详情>>
业绩披露：
2024年年报每股收益-2.85美元,归母净利润-1.52亿美元,同比去年增长-1.96%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.18美元,归母净利润-1.16亿美元,同比去年增长-11.26%
|
| 2024-08-08 |
详情>>
业绩披露：
2023年中报每股收益-1.62美元,归母净利润-7112.9万美元,同比去年增长-4.4%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-1.49美元,归母净利润-7871.9万美元,同比去年增长-10.67%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.67美元,归母净利润-3532.6万美元,同比去年增长-0.43%
|
| 2024-04-29 |
股东大会：
将于2024-06-21召开股东大会
会议内容 ▼▲
- 1.Elect the three Class III directors named as nominees in this Proxy Statement to hold office until the 2027 annual meeting of stockholders (the “2027 Annual Meeting”) and until their respective successors have been duly elected and qualified;
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.Transact any other business properly introduced at the Annual Meeting.
|
| 2024-03-19 |
详情>>
拆分方案：
每5.0000合并分成1.0000股
|
| 2024-03-15 |
详情>>
业绩披露：
2023年年报每股收益-0.66美元,归母净利润-1.49亿美元,同比去年增长-1.38%
|
| 2023-11-30 |
股东大会：
将于2023-12-18召开股东大会
会议内容 ▼▲
- 1.Elect the two Class II directors named as nominees in this Proxy Statement to hold office until the 2026 annual meeting of stockholders (the “2026 Annual Meeting”) and until their respective successors have been duly elected and qualified;
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.Approve an amendment to our certificate of incorporation to provide the Board of Directors with the right to decide at its discretion to effect a reverse stock split at a ratio of not less than 1-for-2 and not greater than 1-for-30, with the exact ratio and effective time of the reverse stock split, if any, to be determined by our Board of Directors at any time within one year of the date of the 2023 Annual Meeting;
4.Approve certain securities issuances for the purpose of complying with New York Stock Exchange rules;
5.Transact any other business properly introduced at the Annual Meeting.
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.47美元,归母净利润-1.04亿美元,同比去年增长0.25%
|
| 2022-10-04 |
股东大会：
将于2022-11-18召开股东大会
会议内容 ▼▲
- 1.Elect the Class I director named in our Proxy Statement to hold office until the 2025 annual meeting of stockholders (the “2025 Annual Meeting”) and until their respective successors have been duly elected and qualified;
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.Approve an amendment to our 2021 Incentive Award Plan to (i) increase the number of shares of our common stock reserved for issuance, and (ii) implement an evergreen share reserve increase pursuant to which the number of shares of our common stock reserved for issuance under the Incentive Plan will increase on an annual basis;
4.Approve our Employee Stock Purchase Plan to provide our eligible employees an opportunity to acquire our common stock from us;
5.Advisory (non-binding) vote to approve the compensation of our named executive officers;
6.Advisory (non-binding) vote on the frequency of future advisory votes on executive compensation;
7.Transact any other business properly introduced at the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-15 |
复牌提示：
2021-03-15 11:25:45 停牌，复牌日期 2021-03-15 11:31:35
|
| 2021-02-16 |
股东大会：
将于2021-03-11召开股东大会
会议内容 ▼▲
- 1.The “Business Combination Proposal”-to consider and vote on a proposal to approve and adopt the Business Combination Agreement, dated as of November 2, 2020 (as it may be amended and/or restated from time to time, the “Business Combination Agreement”), by and among InterPrivate, Aeva, Inc. (“Aeva”) and WLLY Merger Sub Corp. (“Merger Sub”), and the transactions contemplated thereby, pursuant to which Merger Sub will merge with and into Aeva, with Aeva surviving the merger and becoming a wholly-owned direct subsidiary of InterPrivate (collectively with the other transactions described in the Business Combination Agreement, the “Business Combination”);
2.The “Charter Amendment Proposal”-to consider and vote on a proposal to adopt the proposed second amended and restated certificate of incorporation of InterPrivate attached as Annex B to the proxy statement/prospectus/consent solicitation statement (the “Charter Amendment Proposal”);
3.The “Governance Proposals”-to consider and vote on, on a non-binding advisory basis, eight separate governance proposals relating to the following material differences between InterPrivate’s current amended and restated certificate of incorporation and the proposed second amended and restated certificate of incorporation (collectively, the “Governance Proposals”):
3.1.change the name of InterPrivate to “Aeva Technologies, Inc.” from the current name of “InterPrivate Acquisition Corp.” and remove certain provisions related to InterPrivate’s status as a special purpose acquisition company that will no longer be relevant following the closing of the Business Combination (the “Closing”);
3.2.increase the number of shares of (i) common stock InterPrivate is authorized to issue from 50,000,000 shares to 422,000,000 shares and (ii) preferred stock InterPrivate is authorized to issue from 1,000,000 shares to 10,000,000 shares;
3.3.require the vote of at least two-thirds of the voting power of the outstanding shares of capital stock, rather than a simple majority, to adopt, amend or repeal the Post-Combination Company’s bylaws;
3.4.require the vote of at least two-thirds of the voting power of the outstanding shares of capital stock, rather than a simple majority, to remove a director from office;
3.5.require the vote of at least two-thirds of the voting power of the outstanding shares of capital stock, rather than a simple majority, to amend or repeal certain provisions of the Proposed Certificate of Incorporation;
3.6.remove the provision renouncing the corporate opportunity doctrine;
3.7.require that special meetings of stockholders may only be called by the board of directors, the chairperson of the board of directors or the chief executive officer and not by stockholders, subject to any special rights of the holders of preferred stock;
3.8.modify the forum selection provision to designate the U.S. federal district courts as the exclusive forum for claims arising under the Securities Act rather than providing for concurrent jurisdiction in the Court of Chancery and the federal district court for the District of Delaware for claims arising under the Securities Act;
4.The “Election of Directors Proposal”-to consider and vote on a proposal to elect, effective at Closing, five directors to serve staggered terms on our board of directors until the 2022, 2023 and 2024 annual meetings of stockholders, respectively, and until their respective successors are duly elected and qualified;
5.The “Incentive Award Plan Proposal”-to consider and vote on a proposal to approve and adopt the incentive award plan established to be effective after the Closing of the Business Combination;
6.The “NYSE Proposal”-to consider and vote on a proposal to issue InterPrivate Common Stock to the Aeva stockholders in the Business Combination and to the investors in the PIPEs;
7.The “Adjournment Proposal”-to consider and vote on a proposal to adjourn the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are not sufficient votes to approve one or more proposals presented to stockholders for vote.
|